Citigroup’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80.9M Buy
248,238
+53,504
+27% +$17.4M 0.04% 298
2025
Q1
$52.6M Buy
194,734
+107,837
+124% +$29.1M 0.03% 400
2024
Q4
$20.4M Buy
86,897
+12,626
+17% +$2.97M 0.01% 637
2024
Q3
$20.4M Sell
74,271
-327,389
-82% -$90M 0.01% 646
2024
Q2
$97.6M Buy
401,660
+250,970
+167% +$61M 0.06% 210
2024
Q1
$22.5M Buy
150,690
+77,889
+107% +$11.6M 0.01% 591
2023
Q4
$13.9M Sell
72,801
-6,698
-8% -$1.28M 0.01% 723
2023
Q3
$14.1M Buy
79,499
+18,295
+30% +$3.24M 0.01% 675
2023
Q2
$11.6M Sell
61,204
-17,657
-22% -$3.35M 0.01% 781
2023
Q1
$15.8M Sell
78,861
-117,400
-60% -$23.5M 0.01% 678
2022
Q4
$46.6M Buy
196,261
+12,231
+7% +$2.91M 0.04% 303
2022
Q3
$36.8M Buy
184,030
+44,038
+31% +$8.81M 0.03% 343
2022
Q2
$20.4M Buy
139,992
+82,983
+146% +$12.1M 0.02% 562
2022
Q1
$9.31M Sell
57,009
-12,301
-18% -$2.01M 0.01% 936
2021
Q4
$11.8M Sell
69,310
-1,682
-2% -$285K 0.01% 875
2021
Q3
$13.4M Sell
70,992
-12,160
-15% -$2.3M 0.01% 863
2021
Q2
$14.1M Sell
83,152
-2,325
-3% -$394K 0.01% 895
2021
Q1
$12.1M Buy
85,477
+19,962
+30% +$2.82M 0.01% 936
2020
Q4
$8.52M Sell
65,515
-37,072
-36% -$4.82M 0.01% 1045
2020
Q3
$14.9M Buy
102,587
+48,994
+91% +$7.13M 0.01% 670
2020
Q2
$7.94M Buy
53,593
+13,395
+33% +$1.98M 0.01% 891
2020
Q1
$4.37M Sell
40,198
-16,710
-29% -$1.82M ﹤0.01% 999
2019
Q4
$6.56M Sell
56,908
-43,894
-44% -$5.06M ﹤0.01% 1026
2019
Q3
$8.11M Buy
100,802
+70,078
+228% +$5.64M 0.01% 884
2019
Q2
$2.23M Buy
30,724
+18,978
+162% +$1.38M ﹤0.01% 1564
2019
Q1
$1.1M Sell
11,746
-67,301
-85% -$6.29M ﹤0.01% 1904
2018
Q4
$5.76M Buy
79,047
+28,913
+58% +$2.11M 0.01% 945
2018
Q3
$4.39M Buy
50,134
+11,947
+31% +$1.05M ﹤0.01% 1065
2018
Q2
$3.76M Sell
38,187
-15,409
-29% -$1.52M ﹤0.01% 1154
2018
Q1
$6.38M Sell
53,596
-31,500
-37% -$3.75M 0.01% 874
2017
Q4
$10.8M Buy
85,096
+52,519
+161% +$6.67M 0.01% 654
2017
Q3
$3.83M Sell
32,577
-17,156
-34% -$2.02M ﹤0.01% 1103
2017
Q2
$3.97M Buy
49,733
+5,214
+12% +$416K ﹤0.01% 1067
2017
Q1
$2.28M Sell
44,519
-86,520
-66% -$4.43M ﹤0.01% 1321
2016
Q4
$4.91M Buy
131,039
+36,612
+39% +$1.37M ﹤0.01% 1058
2016
Q3
$6.4M Buy
94,427
+13,551
+17% +$919K 0.01% 739
2016
Q2
$4.49M Buy
80,876
+6,647
+9% +$369K ﹤0.01% 853
2016
Q1
$4.66M Buy
74,229
+3,794
+5% +$238K 0.01% 864
2015
Q4
$6.63M Sell
70,435
-24,842
-26% -$2.34M 0.01% 734
2015
Q3
$7.66M Buy
95,277
+12,769
+15% +$1.03M 0.01% 681
2015
Q2
$9.89M Buy
82,508
+3,756
+5% +$450K 0.01% 591
2015
Q1
$8.22M Buy
78,752
+47,827
+155% +$4.99M 0.01% 663
2014
Q4
$3M Sell
30,925
-54,686
-64% -$5.31M ﹤0.01% 1070
2014
Q3
$6.69M Buy
85,611
+70,281
+458% +$5.49M 0.01% 746
2014
Q2
$968K Sell
15,330
-5,573
-27% -$352K ﹤0.01% 1624
2014
Q1
$1.4M Sell
20,903
-4,625
-18% -$310K ﹤0.01% 1370
2013
Q4
$1.64M Buy
25,528
+5,841
+30% +$376K ﹤0.01% 1501
2013
Q3
$1.26M Buy
19,687
+10,009
+103% +$641K ﹤0.01% 1425
2013
Q2
$300K Buy
+9,678
New +$300K ﹤0.01% 2420